Mehmet Kocoglu, MD

Mehmet Kocoglu, MD

Assistant Professor, Director of chimeric antigen receptor T-cell (CAR-T cell) for multiple myeloma

Research Focus:
Dr. Kocoglu focuses on the treatment of multiple myeloma including high-risk myeloma. He specializes in cellular therapies of myeloma including stem cell transplantation as well as CART cell and bispecific antibody (i.e. biologic) therapies of myeloma, AL amyloidosis and POEMS syndrome.

years treating myeloma: 17

Number of Myeloma Patients Treated Annually: 650

Details & contact info

University of Maryland School of Medicine

Cider Alley Ridgleys Delight
Baltimore, MD, United States, 21201


View Full Physician Bio

View Website

Send a message to Mehmet Kocoglu, MD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .